[HTML][HTML] Combating deleterious phase transitions in neurodegenerative disease

AL Darling, J Shorter - Biochimica et Biophysica Acta (BBA)-Molecular Cell …, 2021 - Elsevier
Protein aggregation is a hallmark of neurodegenerative diseases. However, the mechanism
that induces pathogenic aggregation is not well understood. Recently, it has emerged that …

[引用][C] Combating deleterious phase transitions in neurodegenerative disease

AL Darling, J Shorter - Biochimica et Biophysica Acta (BBA)-Molecular …, 2021 - cir.nii.ac.jp
Combating deleterious phase transitions in neurodegenerative disease | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Combating deleterious phase transitions in neurodegenerative disease

AL Darling, J Shorter - Biochimica et biophysica acta …, 2021 - pubmed.ncbi.nlm.nih.gov
Protein aggregation is a hallmark of neurodegenerative diseases. However, the mechanism
that induces pathogenic aggregation is not well understood. Recently, it has emerged that …

Combating deleterious phase transitions in neurodegenerative disease.

AL Darling, J Shorter - … et Biophysica acta. Molecular Cell Research, 2021 - europepmc.org
Protein aggregation is a hallmark of neurodegenerative diseases. However, the mechanism
that induces pathogenic aggregation is not well understood. Recently, it has emerged that …

[PDF][PDF] Combating deleterious phase transitions in neurodegenerative disease

AL Darling, J Shorter - med.upenn.edu
Protein aggregation is a hallmark of neurodegenerative diseases. However, the mechanism
that induces pathogenic aggregation is not well understood. Recently, it has emerged that …

[HTML][HTML] Combating deleterious phase transitions in neurodegenerative disease

AL Darling, J Shorter - … et biophysica acta. Molecular cell research, 2021 - ncbi.nlm.nih.gov
Protein aggregation is a hallmark of neurodegenerative diseases. However, the mechanism
that induces pathogenic aggregation is not well understood. Recently, it has emerged that …